Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study.

Welzel TM, Mellemkjaer L, Gloria G, Sakoda LC, Hsing AW, El Ghormli L, Olsen JH, McGlynn KA.

Int J Cancer. 2007 Feb 1;120(3):638-41.

2.

Liver stem cells and their implication in hepatocellular and cholangiocarcinoma.

Roskams T.

Oncogene. 2006 Jun 26;25(27):3818-22. Review.

PMID:
16799623
3.
4.

A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States.

McGlynn KA, Tarone RE, El-Serag HB.

Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1198-203.

5.

New insights to the immunopathology and autoimmune responses in primary biliary cirrhosis.

He XS, Ansari AA, Ridgway WM, Coppel RL, Gershwin ME.

Cell Immunol. 2006 Jan;239(1):1-13. Review.

PMID:
16765923
6.

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.

Leandro G, Mangia A, Hui J, Fabris P, Rubbia-Brandt L, Colloredo G, Adinolfi LE, Asselah T, Jonsson JR, Smedile A, Terrault N, Pazienza V, Giordani MT, Giostra E, Sonzogni A, Ruggiero G, Marcellin P, Powell EE, George J, Negro F; HCV Meta-Analysis (on) Individual Patients' Data Study Group..

Gastroenterology. 2006 May;130(6):1636-42.

PMID:
16697727
7.

Helicobacter pylori and other Helicobacter species DNA in human bile samples from patients with various hepato-biliary diseases.

Tiwari SK, Khan AA, Ibrahim M, Habeeb MA, Habibullah CM.

World J Gastroenterol. 2006 Apr 14;12(14):2181-6.

8.

Prevalence of overweight and obesity in the United States, 1999-2004.

Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM.

JAMA. 2006 Apr 5;295(13):1549-55.

PMID:
16595758
9.

Caroli's disease.

Gupta AK, Gupta A, Bhardwaj VK, Chansoria M.

Indian J Pediatr. 2006 Mar;73(3):233-5.

PMID:
16567920
10.

Primary sclerosing cholangitis can present with acute liver failure: Report of two cases.

Bergquist A, Glaumann H, Lindberg B, Broomé U.

J Hepatol. 2006 May;44(5):1005-8.

PMID:
16551483
11.

Nonalcoholic steatohepatitis (NASH) with diabetes: predictors of liver fibrosis.

Amarapurka DN, Amarapurkar AD, Patel ND, Agal S, Baigal R, Gupte P, Pramanik S.

Ann Hepatol. 2006 Jan-Mar;5(1):30-3.

PMID:
16531962
12.

Treatment of alcoholic pancreatitis.

Pfutzer RH, Schneider A.

Dig Dis. 2005;23(3-4):241-6. Review.

PMID:
16508288
13.

Primary sclerosing cholangitis and cholangiocarcinoma.

Lazaridis KN, Gores GJ.

Semin Liver Dis. 2006 Feb;26(1):42-51. Review.

PMID:
16496232
14.

Primary sclerosing cholangitis: epidemiology, natural history, and prognosis.

Levy C, Lindor KD.

Semin Liver Dis. 2006 Feb;26(1):22-30. Review.

PMID:
16496230
15.

Etiopathogenesis of primary sclerosing cholangitis.

O'Mahony CA, Vierling JM.

Semin Liver Dis. 2006 Feb;26(1):3-21. Review.

PMID:
16496229
16.

Differential effects of experimental and cold-induced hyperthyroidism on factors inducing rat liver oxidative damage.

Venditti P, Pamplona R, Ayala V, De Rosa R, Caldarone G, Di Meo S.

J Exp Biol. 2006 Mar;209(Pt 5):817-25.

17.

Nonalcoholic fatty liver disease: from steatosis to cirrhosis.

Farrell GC, Larter CZ.

Hepatology. 2006 Feb;43(2 Suppl 1):S99-S112. Review.

PMID:
16447287
18.

Endoscopic therapy of benign biliary strictures.

Matlock J, Freeman ML.

Rev Gastroenterol Disord. 2005 Fall;5(4):206-14. Review.

PMID:
16369216
19.

Steatosis is a cofactor in liver injury in hemochromatosis.

Powell EE, Ali A, Clouston AD, Dixon JL, Lincoln DJ, Purdie DM, Fletcher LM, Powell LW, Jonsson JR.

Gastroenterology. 2005 Dec;129(6):1937-43.

PMID:
16344062
20.

Liver cancer: the role of stem cells.

Alison MR, Lovell MJ.

Cell Prolif. 2005 Dec;38(6):407-21. Review.

PMID:
16300653
Items per page

Supplemental Content

Support Center